Health
Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants – Newswise
Researchers at La Jolla Institute for Immunology (LJI) have found that T cells from people who have recovered from COVID-19 or…
Newswise — LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) have found that T cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize several concerning SARS-CoV-2…
Continue Reading
-
General22 hours agoToni Lamond, known for her roles in Annie Get Your Gun and My Fair Lady, dies aged 93
-
General23 hours agoPolice continue search for missing man Chris Thorne in Melbourne’s west
-
General23 hours agoPauline Hanson proves we have a two-tier senate
-
Business10 hours agoRanking the best “Magnificent Seven” stocks to buy for 2026. Here’s my No. 5 pick.